Australian Patients Losing Monthly Opioid Injection, Forced Back to Daily Pills

Indivior is pulling Sublocade—a monthly buprenorphine injection—from Australia by end-2026. The drug was built to solve the compliance problem of daily pills. Stable patients, especially those with poor track records, must now switch to daily medication or methadone. A rival weekly injection offers some options but isn't equivalent for everyone. Clinicians will have to manage each case carefully through the transition.